Focus on HER2 in cancer: Summary
HER2 dysregulation is an important step in tumor growth
- Gene amplification and receptor overexpression can create an excess of HER2 signaling1
- HER2 signaling can lead to multiple effects on cancer cells, including5:
- Cell proliferation
- DNA synthesis
- Tumorigenesis
- HER2 is the preferred dimerization partner for all HER family receptors2
- HER2/HER3 and HER1/HER2 heterodimers are of particular importance in cancer3,4,6
HER2 is a negative prognostic factor
- HER2 is correlated with poor outcomes in
- Breast cancer11-13
- Increased relative risk
- Shorter overall survival
- Ovarian cancer14
- Shorter overall survival
- Breast cancer11-13
HER2 represents a therapeutic target
- HER2 has been successfully targeted in breast cancer and is being investigated as a potential therapeutic target in ovarian cancer
- Methods of targeting the HER2 receptor under investigation include:
- Prevention of receptor activation by binding to the extracellular domain of the receptor28
- Prevention of HER2 dimerization28
- Inhibiting phosphorylation of the tyrosine kinase domain of the receptor4
- Inhibiting HER pathway signaling intermediates4
Additional clinical research is necessary to further clarify the relationship between HER2 and cancer.

